The global fertility test market size is expected to reach USD 830.6 million by 2028 according to a new study by Polaris Market Research. The report “Fertility Test Market Share, Size, Trends, Industry Analysis Report, By Product; By Mode of Purchase (Direct/Prescription Products, OTC Products, Online Products); By Application (Female Testing, Male Testing); By End-Use (Home Care Settings, Hospitals & Fertility Centers, Others); By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Fecundity examination is performed in males and females to evaluate their fecundity and numerous conditions related to it. Both women and men experience fecundity difficulties, but women are more worried about fecundity issues. The general physician or gynecologist primarily assesses the fecundity examination outcomes to examine the precise concern and counsels the remedial treatment.
Furthermore, the fecundity rate in China is following a downward trend, owing to its one-child policy. As per the statistics introduced by the National Bureau of Statistics of China, the country saw a substantial decline in birth rate from 1.3 to 1. 2 percent in 2017. Hence, reducing fecundity rates and faulty lifestyles among Chinese women is projected to drive the region’s market growth.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/fertility-test-market/request-for-sample
OTC segment is projected to hold the majority of the revenue share, owing to increasing preference of patients towards self-care, favorable government initiatives, and the concerned awareness initiatives about the cause and probable ill-effects of fecundity.
Moreover, rising confidentiality and the convenience of getting results are expected to boost the segment’s growth prospects. Online sales are anticipated to grow in the coming future, primarily due to less time to shop and the ongoing COVID-19 pandemic, causing people to stay indoors.
Market participants such as Babystart, AdvaCare Pharma, bioZhena Corporation, ExSeed Health, Church & Dwight Co., Inc., fecundity Focus Limited, Fairhaven Health, Geratherm Medical, Medical Electronic Systems, HILIN LIFE PRODUCTS, Mira Care, Swiss Precision Diagnostics, PREGMATE, Tempdrop, UEBE Medical GmbH, Tracxn Technologies, and Valley Electronics AG are some of the key players operating in the global market.
Market players in the fecundity examination industry are developing novel product launches to stay competitive. For instance, in February 2021, the UK-based fecundity Focus collaborated with ExSeed Health, a home-based solution for sperm taxing. Under the agreement, both firms would deliver solutions to couples planning to have a child.
Polaris Market Research has segmented the fertility test market report on the basis of product, mode of purchase, application, end-use, and region:
Fertility Test, Product Outlook (Revenue – USD Million, 2016 – 2028)
- Ovulation Prediction Kits
- Fertility Monitors
- Urine-Based Monitors
- Saliva-Based Monitors
- Other Fertility Monitors
- Male Fertility Products
Fertility Test, Mode of Purchase Outlook (Revenue – USD Million, 2016 – 2028)
- Direct/Prescription Products
- OTC Products
- Online Products
Fertility Test, Application Outlook (Revenue – USD Million, 2016 – 2028)
- Female Testing
- Male Testing
Fertility Test, End-Use Outlook (Revenue – USD Million, 2016 – 2028)
- Home Care Settings
- Hospitals And Fertility Centers
Fertility Test, Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa